The Argenta website uses cookies to store information on your computer, to improve our website. One of the cookies we use is essential for parts of the site to operate and has already been set. You may delete and block all cookies from this site, but parts of the site will not work. To find out more about the cookies we use and how to delete them, see our privacy notice.

I accept cookies from this site
 

In this section...

ADMET / PK

Dr Donald Daley directs Argenta's ADMET and PK team, who work closely with our chemistry and biology teams, providing essential information on the vulnerability of compounds to help direct medicinal chemistry activities.

Our approach is to address ADMET as early as appropriate in the discovery process, and we provide a cascade of approaches ranging from early in vitro assessment to pharmacokinetics.

For more information on our ADMET & PK capabilities please contact us.


Print to HTML

Innovation. Expertise. Delivered